Peregrine Capital Management LLC Spring Works Therapeutics, Inc. Transaction History
Peregrine Capital Management LLC
- $3.18 Billion
- Q3 2024
A detailed history of Peregrine Capital Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 165,534 shares of SWTX stock, worth $6.02 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
165,534
Previous 136,563
21.21%
Holding current value
$6.02 Million
Previous $5.14 Million
3.09%
% of portfolio
0.17%
Previous 0.16%
Shares
8 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$204 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$140 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$128 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$124 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.27B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...